These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38989832)

  • 1. An Awareness of Pharmacovigilance Among Healthcare Professionals Due to an Underreporting of Adverse Drug Reactions Issue: A Systematic Review of the Current State, Obstacles, and Strategy.
    Putri RA; Ikawati Z; Rahmawati F; Yasin NM
    Curr Drug Saf; 2024; 19(3):317-331. PubMed ID: 38989832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, attitude and practice of Malaysian healthcare professionals toward adverse drug reaction reporting: a systematic review.
    Balan S
    Int J Pharm Pract; 2021 Aug; 29(4):308-320. PubMed ID: 34289016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.
    Khan Z; Karatas Y; Hamid SM
    PLoS One; 2023; 18(5):e0285811. PubMed ID: 37224133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
    Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
    Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
    Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
    Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Educational interventions in pharmacovigilance to improve the knowledge, attitude and the report of adverse drug reactions in healthcare professionals: Systematic Review and Meta-analysis.
    Cervantes-Arellano MJ; Castelán-Martínez OD; Marín-Campos Y; Chávez-Pacheco JL; Morales-Ríos O; Ubaldo-Reyes LM
    Daru; 2024 Jun; 32(1):421-434. PubMed ID: 38427161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update.
    García-Abeijon P; Costa C; Taracido M; Herdeiro MT; Torre C; Figueiras A
    Drug Saf; 2023 Jul; 46(7):625-636. PubMed ID: 37277678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia.
    Seid MA; Kasahun AE; Mante BM; Gebremariam SN
    Int J Clin Pharm; 2018 Aug; 40(4):895-902. PubMed ID: 30094559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
    Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
    J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reaction Reporting in Ethiopia: Systematic Review.
    Hailu AD; Mohammed SA
    Biomed Res Int; 2020; 2020():8569314. PubMed ID: 32851089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge, attitude and practice towards pharmacovigilance and reporting of adverse drug reactions among health care professionals in Albania: A cross-sectional study.
    Shkreli R; Dhamo K; Haloçi E; Tabaku A
    Pak J Pharm Sci; 2023 May; 36(3):713-721. PubMed ID: 37580918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature.
    Reumerman M; Tichelaar J; Piersma B; Richir MC; van Agtmael MA
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1235-1248. PubMed ID: 29926135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring pharmacovigilance practices and knowledge among healthcare professionals: A cross-sectional multicenter study.
    Hayek A; Sridhar SB; Rabbani SA; Shareef J; Wadhwa T
    SAGE Open Med; 2024; 12():20503121241249908. PubMed ID: 38725923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with underreporting of adverse drug reactions by patients: a systematic review.
    Costa C; Abeijon P; Rodrigues DA; Figueiras A; Herdeiro MT; Torre C
    Int J Clin Pharm; 2023 Dec; 45(6):1349-1358. PubMed ID: 37247159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework.
    Li R; Curtis K; Van C; Tabish Razi Zaidi S; Yeo CY; Arun Kali C; Zaheen M; Therese Moujalli G; Castelino R
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1165-1175. PubMed ID: 35476123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reaction reporting via mobile applications: A narrative review.
    Leskur D; Bozic J; Rusic D; Seselja Perisin A; Cohadzic T; Pranic S; Modun D; Bukic J
    Int J Med Inform; 2022 Dec; 168():104895. PubMed ID: 36252337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
    Mulchandani R; Kakkar AK
    Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.